Olecranon Bursitis: Septic or Not, and What the Treatment Evidence Actually Shows

Key Takeaways

Olecranon bursitis is a fluid-filled swelling over the point of the elbow. Most cases are non-infectious, but a meaningful minority are septic, and telling them apart is the central clinical question.
No single exam finding reliably separates septic from aseptic cases: tenderness, redness, warmth and fever are all more common in septic cases, yet the clinical and laboratory pictures overlap.
For aseptic olecranon bursitis, a small randomized trial found no statistically significant difference in 4-week resolution between conservative care, aspiration, and aspiration plus steroid injection. Steroid injection shortened time to resolution in some studies, while systematic reviews linked it to more complications, including infection and skin atrophy.
In emergency-department data, most patients with suspected septic bursitis who received empiric antibiotics without aspiration recovered without further procedures.
In clinical practice, aseptic olecranon bursitis often presents as a painless, tense, fluid-filled bulge that mainly bothers patients when they lean on the elbow; elbow movement and function are usually unaffected.
In my clinical experience, aspirated sterile bursae occasionally become infected and can be hard to treat, which is why I am cautious about draining a calm, painless bursa or a traumatic bursa under intact skin, even though the 2014 systematic review did not find a higher infection rate after aspiration.
Surgery (bursectomy) is associated with more complications than nonsurgical management, and roughly one in nine patients needed revision surgery in one large series.
Repeated elbow impact and pressure matter: in military recruits, incidence was 97 per 100,000 person-years in combat duty versus 29 per 100,000 overall.

Introduction: More Than a Swollen Elbow

Olecranon bursitis sits in an awkward spot clinically. It can look dramatic, as a soft swelling on the back of the elbow, yet most cases are not infected. At the same time, a subset of cases are infected, and those need different management.

How common is it? In a study of 2,692 Israeli soldiers diagnosed with the condition, the crude annual incidence was 29 per 100,000 person-years, rising to 97 per 100,000 person-years among soldiers in combat duty.[1] A 1996 emergency-department management review stated that one third of episodes are septic.[2]

It also sits where clinical medicine and contact sport meet: it is a diagnosis that requires ruling out infection, and repeated elbow contact with mats, floors and hard surfaces is a plausible contributor. This article covers what olecranon bursitis is, who gets it, how septic and aseptic forms are distinguished, and what the research says about each treatment option — including where the evidence is weaker than routine practice suggests.

What Is Olecranon Bursitis?

The olecranon bursa is a thin, fluid-filled sac lying between the skin and the bony tip of the elbow (the olecranon process of the ulna). Because of its superficial location and limited blood supply, the bursa is susceptible to repeated trauma and infection.[3]

When the bursa becomes irritated or infected, it fills with fluid. The condition is broadly divided into two types:

Aseptic (non-infectious) olecranon bursitis — associated with trauma, including repetitive elbow trauma,[1] or with an underlying condition such as rheumatoid arthritis or gout.[4]
Septic olecranon bursitis — bacterial infection of the bursa.

In a classic comparison of 30 olecranon and prepatellar bursitis cases (ten of them septic), the authors noted that rheumatoid arthritis and gout may be accompanied by non-septic bursitis.[4]

In general practice, olecranon bursitis is not an everyday diagnosis, but every now and then a patient comes in to show me a lump on the back of the elbow. In my clinical experience, a swelling that is not painful and looks clinically calm is more likely to be aseptic bursitis. Aseptic bursitis often simply feels like a tense, fluid-filled bulge at the tip of the elbow, and when I palpate it, the patient is usually not particularly tender. The size varies: sometimes it is small and barely noticeable, but often it is about the size of half a ping-pong ball, and quite often as large as half an egg.

In my clinical experience, the swelling is mainly a nuisance for many patients, because they like to rest the elbow on something and the bulge catches on it; many only notice it when they lean on the elbow. The elbow itself is otherwise non-tender, and range of motion and other function are often normal. In some situations, extreme flexion may cause a feeling of tightness over the bursa, but in general the elbow joint itself is not particularly affected.

Who Gets It? Risk Factors

A large population-based risk-factor study analyzed an Israeli health-insurer database from 2005 to 2020, comparing 10,301 patients with olecranon bursitis against 44,608 controls.[5] After statistical weighting, the condition was significantly associated with:

male sex (OR 1.406)
hyperlipidemia (OR 1.243)
statin use (OR 1.130)
smoking (OR 1.068)

These odds ratios are from the study’s results table; the abstract reports slightly different values for hyperlipidemia (1.239) and statin use (1.117).[5]

Diabetes and cerebrovascular events showed no significant association in that cohort.[5] Two caveats matter here: these are associations, not proof of cause, and because diagnoses came from ICD codes, the database did not record whether cases were septic or aseptic.[5]

Mechanical load also appears to matter. In the military cohort, the type of service was the main risk factor, and the authors suggested the higher incidence in combat units was possibly related to field training without protective gear and repetitive trauma to the elbows; they named protective gear as the most promising preventive measure.[1] In administrative (non-manual) units, incidence was similar in women (8.4 per 100,000 person-years) and men (11 per 100,000 person-years).[1]

In practice, there is often some kind of strain or knock in the background. A patient may have bumped the elbow against a table or another hard surface, or the cause may simply be leaning on the elbow, on a desk or an armrest, for example. Many patients cannot point to any specific moment when it started; they just notice a bulge and come in to have it checked. In my experience, bursitis can also develop from load alone: from sports training, or in people who do manual work, where repeated use of the arms may be enough to irritate the bursa.

Septic vs. Aseptic Olecranon Bursitis: How They Are Told Apart

This is the core diagnostic problem, and the studies reviewed here repeatedly note that it can be difficult.

Clinical signs

A review compiling published data reported the following frequencies of key examination findings in septic versus aseptic cases:[6]

Finding	Septic	Aseptic
Tenderness	88%	36%
Erythema/cellulitis	83%	27%
Warmth	84%	56%
Reported trauma or skin lesion	50%	25%
Fever	38%	0%

The pattern is clear — septic bursitis is usually more tender, red and warm — but the overlap is substantial. The authors concluded that distinguishing the two can be difficult because physical and laboratory data overlap.[6] Note also that fever was present in only 38% of septic cases, so the absence of fever does not by itself rule out infection.

The older comparison study likewise found fever, tenderness, peribursal cellulitis and skin involvement more often in septic cases.[4]

Bursal fluid analysis

When fluid is aspirated, laboratory testing adds information. In the 1979 series, a high leukocyte count, a low bursal-to-serum glucose ratio and a positive Gram stain distinguished septic from non-septic bursitis.[4] A prospective BMJ study of 36 patients with olecranon or prepatellar bursitis (17 septic, 19 non-septic) found median bursal fluid white cell counts of 5.2 ×10⁹/l (range 1.2–34.6) in septic cases versus 1.3 ×10⁹/l (range 0.1–6.1) in non-septic cases.[7] In the same study, clinical features alone could not identify all septic cases, and the volume and appearance of the aspirate did not help.[7] The ranges overlap, which is why cell counts support rather than settle the diagnosis.

The causative organisms

Staphylococcus aureus dominates. In a Geneva series of 343 hospitalized episodes of infectious olecranon and patellar bursitis, it accounted for 85% of the 256 cases with an identified pathogen.[8] In a Mayo Clinic series of 91 surgically treated septic cases, it was the most common pathogen at 64%.[9]

A sports-specific warning

A case report from a sports medicine clinic described two septic olecranon cases and one septic prepatellar case in adult hockey players.[10] The authors noted that septic bursitis is often not considered unless there is a local skin lesion or fever. In one olecranon case, the swelling was first diagnosed as acute traumatic bursitis; on the second day the patient developed spreading redness and warmth of the forearm and a temperature of 38.3 °C.[10] In the military cohort, septic bursitis made up 24% of all cases and 32% of cases in combat soldiers.[1]

Septic bursitis is always a possibility, and in practice it is a somewhat different situation. A septic bursa is usually red, warm, painful and swollen, and there may be cellulitis-like spreading redness, sometimes even erysipelas. In my clinical experience, there is often a break in the skin through which bacteria have entered, although a visible skin lesion is not always present, as one of the hockey cases above illustrates.[10] These cases tend to be more acute, and the patient may have systemic symptoms. Fortunately, I come across septic cases only rarely.

Treating Aseptic Bursitis: What the Evidence Shows

Systematic review evidence

A 2014 systematic review of 29 studies with 1,278 patients — based mainly on level IV evidence — found that corticosteroid injection for aseptic olecranon bursitis was associated with more overall complications and more skin atrophy, while aspiration did not increase the risk of bursal infection.[11] The authors concluded that steroid injection carries significant risks without improving the outcome of aseptic bursitis.[11]

A 2023 systematic review of non-surgical treatment included two randomized controlled trials and two observational studies.[3] The RCTs had a high risk of bias and neither showed a significant difference in resolution or bursal tenderness between invasive and non-invasive options. Steroid injection shortened symptom duration but was associated with more complications, including bursal infection and skin atrophy. The authors suggested that conservative methods can resolve aseptic bursitis, particularly when started earlier, and that steroid injection should be reserved for refractory cases.[3]

The key randomized trial

In a two-center trial, 90 patients with non-septic olecranon bursitis were randomized to compression bandaging with NSAIDs, aspiration alone, or aspiration with steroid injection (30 per group).[12] No statistically significant difference in resolution by week 4 was detected between the groups. Aspiration plus steroid gave the fastest resolution (median 2.3 weeks) compared with aspiration alone (3.1 weeks) and compression with NSAIDs (3.2 weeks). Seven patients were lost to follow-up, leaving 83 in the analysis. A longer symptom duration before treatment was the only factor associated with treatment failure. No complications such as infection or skin atrophy were observed, although the authors noted that the trial might be too small to detect uncommon complications. Given the recurrence risk and the complications of aspiration and injection, the authors suggested that compression bandaging with a short NSAID course may offer the most appropriate balance of safety and efficacy.[12]

The steroid trade-off in older studies

The trade-off is not new. In a 1984 follow-up of 47 patients with traumatic bursitis (mean follow-up 31 months), the 22 treated with aspiration recovered more slowly but had no treatment complications. The 25 who received an intrabursal triamcinolone hexacetonide injection usually recovered within a week but experienced infection (3 cases), skin atrophy (5 cases) and chronic local pain (7 cases).[13] Because spontaneous resolution can be expected, the authors favored a conservative approach.[13]

Not every study points the same way. A 1989 double-blind trial of 42 patients compared intrabursal steroid with an oral anti-inflammatory and concluded that a 20 mg methylprednisolone acetate injection appeared to be the most effective regimen.[14] Taken together, these studies suggest that steroid injection may speed resolution. However, complications including infection and skin atrophy have been reported in some studies, while others observed no such complications.

In my clinical experience, patients with aseptic olecranon bursitis tend to fall into two groups: for some the swelling is a real nuisance, while others are not bothered by it at all. The most common question is what should be done about it, and whether it can be drained. One approach is to aspirate the bursa and, once it has been confirmed aseptic, consider a corticosteroid injection if needed. When the swelling bothers the patient, I generally discuss the risk of infection with them, as it has to be weighed against the potential benefit of aspiration.

I have occasionally seen sterile bursae become infected after aspiration, and these infections can be difficult to treat; some patients have needed antibiotic treatment lasting several weeks. For that reason, I have been cautious about aspirating a bursa that is completely painless and clinically calm. This is a clinical impression rather than a measured rate: the 2014 systematic review did not find that aspiration increased the risk of bursal infection in aseptic bursitis.[11] In practice, some patients clearly want the bursa aspirated and accept the infection risk, while others prefer to leave it alone because it does not trouble them.

Treating Septic Bursitis

Is aspiration always needed?

Many guidelines recommend aspirating a suspected septic bursa before starting antibiotics, despite the absence of robust clinical data supporting this practice.[15] In a retrospective emergency-department cohort of 264 patients (266 cases), 147 were discharged on empiric antibiotics for suspected septic bursitis without aspiration.[15] Of the 134 with follow-up, 118 (88.1%) resolved without later aspiration, surgery or hospitalization; eight (6.0%) later underwent aspiration and nine (6.7%) were admitted for inpatient antibiotics.[15] The authors framed empiric antibiotics without aspiration as a possibly reasonable initial approach for selected patients. Note that “suspected septic” was defined by whether the patient received antibiotics, not by confirmed infection.[15]

In my clinical experience, a septic bursa is sometimes aspirated to confirm the diagnosis, but not always; the decision depends partly on the clinician and on how tense the bursa is. When aspiration is done, a culture is taken readily so that the pathogen’s antibiotic sensitivity can be checked. These patients may need repeated follow-up visits, in some cases the bursa has to be incised so that the pus can drain, and treatment can be long, occasionally even requiring hospital-level care. The range of severity is wide.

How long should antibiotics run?

Here the evidence is limited and not fully consistent. In the Geneva cohort of hospitalized patients — 91% of whom were treated surgically — antibiotic courses of 7 days or less showed no significant difference in outcome compared with longer courses, and only immunosuppression was linked to recurrence (OR 5.6).[8] The authors suggested that, in severe hospitalized cases, adjuvant antibiotics after surgery might be limited to 7 days in non-immunosuppressed patients.[8]

The Mayo Clinic series of surgically treated septic cases reported a median postoperative antibiotic duration of 21 days, after excluding patients with initial bacteremia or osteomyelitis. In this retrospective analysis, patients who received no postoperative antibiotics had the highest odds of clinical failure (OR 7.4 relative to a 21-day course); the authors called for a randomized trial to validate the finding.[9] Both studies are retrospective and concern mostly or entirely surgically treated patients, so neither answers the duration question for the larger group managed without surgery.

Surgery: When Conservative Care Fails

Bursectomy (surgical removal of the bursa), open or endoscopic, can be used when patients do not respond to conservative treatment.[16] The evidence counsels caution. In the 2014 systematic review, surgical management was less likely to resolve septic or aseptic bursitis and had higher rates of overall complications, persistent drainage and bursal infection than nonsurgical management.[11]

In a series of 191 patients who underwent olecranon bursectomy, the revision rate was 11.5% (22 patients). Revision was more frequent in women, in patients with rheumatoid arthritis or diabetes, and in those with prior bursitis on either side.[17]

Endoscopic bursectomy is a less invasive alternative. In a comparison of 49 patients (30 with olecranon and 19 with prepatellar bursitis), endoscopic surgery was associated with a shorter hospital stay (0.56 vs. 1 day) and higher patient satisfaction scores (8.5 vs. 5.29) than open surgery; operating time did not differ significantly.[16] This was a small single-center study, so it shows feasibility rather than clear superiority.

Olecranon Bursitis in Athletes

The mechanism the military authors proposed for their combat recruits, repetitive elbow trauma without protective gear,[1] may also be relevant to sports with repeated falls or pressure onto the elbow, although athletes were not studied directly. Two points from the evidence are relevant here:

The “it’s just a bump” assumption is risky. The hockey case report shows how a swelling first labeled traumatic can turn out to be septic within a day,[10] and fever is absent in most septic cases.[6]
Earlier conservative handling of aseptic cases may be associated with better resolution. Longer symptom duration before treatment predicted failure in the randomized trial,[12] and the 2023 review linked earlier conservative management with resolution.[3]

I also see olecranon bursitis in combat sports, usually after the athlete has struck the elbow against something. In acute elbow trauma more broadly, the bursa is often swollen as part of the wider picture, and an elbow contusion may include a small bursitis. This is typically traumatic bursitis, and the bursa may be filled with blood-tinged fluid.

Personally, I would be cautious about draining a traumatic bursa. In my clinical experience, aspiration may offer little benefit in these cases when the skin over the elbow is intact, and I have the impression that these hematomas can become infected after being drained. This reflects my clinical judgment rather than a measured infection rate.

Features the Literature Links to Infection

Based on the studies above, the following features have been associated with septic rather than aseptic bursitis:

marked tenderness, redness or warmth over the bursa[6]
spreading redness (cellulitis) beyond the swelling[4][10]
a reported trauma or a skin lesion over the elbow[6]
fever — present in some septic cases, though its absence does not rule infection out[6]

Conclusion: Olecranon Bursitis Is Usually Benign — but Not Always

Olecranon bursitis has been described as relatively common,[5] and repetitive elbow trauma appears to raise the risk.[1] Most cases are aseptic, but septic cases made up 24% of all cases in the military cohort,[1] and an emergency-department review put the figure at one third.[2] No single sign reliably separates the two.[6]

For aseptic cases, the best available trial found no significant difference in 4-week resolution between compression and NSAIDs, aspiration, or aspiration plus steroid, although steroid injection gave the fastest resolution;[12] systematic reviews have linked steroid injection to a higher complication burden.[3][11] For suspected septic cases, observational emergency-department data show that many patients treated with empiric antibiotics recovered without later aspiration or surgery, although most were never aspirated, so infection was not confirmed,[15] while the optimal antibiotic duration remains unsettled. Surgery is associated with more complications than nonsurgical care and is generally reserved for persistent or refractory cases.[11]

From a clinical perspective, the decision in aseptic cases often comes down to how much the swelling bothers the patient. In my clinical experience, some patients clearly want the bursa aspirated and accept the infection risk, while others prefer to leave a painless bulge alone. Septic bursitis is a different situation: it is usually red, warm and painful, and its treatment can be long, sometimes with incision or hospital-level care.

Much of this evidence is retrospective or small-scale. Within those limits, the consistent message is that many cases of olecranon bursitis resolve with conservative care, and that the occasional infected one is worth taking seriously.